Ftse Mib
36.267,63
1,25%
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
NASDAQ
19.630,20
1,51%
Bitcoin
105.224,02
0,76%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Innate Pharma SA (IPHA) Innate Pharma SA (IPHA) Notizie

Innate Pharma SA

IPHA
1,69
0,02 (1,20%)
18 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/1/202507:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
10/1/202512:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202507:00BW Innate Pharma Announces Transformative Strategy to..
20/12/202407:00BWInnate Pharma annonce sa participation a la 43ème J.P...
09/12/202412:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202407:00BWInnate Pharma présente à l’ASH 2024 des données de l’étude..
06/12/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202407:00BWInnate Pharma et l’Institut d’Innovation pour le Lymphome..
03/12/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/12/202407:00BWInnate Pharma Highlights Abstracts Selected for the ASH..
20/11/202412:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202407:00BWInnate Pharma publie son calendrier financier pour 2025
19/11/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/11/202407:00BWInnate Pharma Announces Publication in Science Immunology..
13/11/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202407:00BWInnate Pharma Reports Third Quarter 2024 Business Update and..
08/11/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202407:00BWInnate Pharma annonce les présentations de données de son..
07/11/202407:00BWInnate Pharma organise une conférence téléphonique pour ses..
29/10/202407:00BWInnate Pharma annonce sa participation à de prochaines..
14/10/202407:00BWJonathan Dickinson est nommé Président du Directoire..
30/9/202407:00BWInnate Pharma co-organise un symposium scientifique en..
23/9/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/9/202407:00BWInnate Pharma Announces FDA Clearance of the IND for..
12/9/202412:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202412:04IHMARKETNEWSU.S. Index Futures Climb Ahead of Key Economic Data..
12/9/202407:00BWInnate Pharma Reports First Half 2024 Business Update and..
11/9/202422:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/9/202407:00BWInnate Pharma SA: Présentation de données de monalizumab..
05/9/202407:00BWInnate Pharma Announces Conference Call and Webcast for..
04/9/202407:00BWInnate Pharma Announces Its Participation in the H.C...
01/8/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
25/7/202407:00BWNouveau nombre d’actions et de droits de vote d’Innate..
18/6/202407:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
17/6/202407:00BWInnate Pharma partage de nouveaux résultats concernant..
04/6/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202407:00BWInnate Pharma Presents Positive Results From TELLOMAK Phase..
28/5/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202407:00BWInnate Pharma annonce sa participation à de prochaines..
24/5/202412:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202407:00BWInnate Pharma partage les abstracts sélectionnés pour le..
23/5/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202422:00BWRésultats de l’Assemblée Générale mixte du 23 mai 2024
21/5/202407:00BWInnate Pharma: Clarification concernant le statut de..
15/5/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202407:00BWInnate Pharma Highlights Abstracts Selected for EHA 2024..
14/5/202407:00BWInnate Pharma fait le point sur ses activités et publie ses..
07/5/202407:00BWInnate Pharma organise une conférence téléphonique pour..
15/4/202407:00BWInnate Pharma annonce la progression de l’essai clinique..
Apertura: 1,74 Min: 1,65 Max: 1,74
Chiusura: 1,67

La tua Cronologia

NASDAQ
IPHA
Innate Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network